The Collagen VI-related Myopathies Ullrich Congenital Muscular Dystrophy and Bethlem Myopathy

Overview

Journal Handb Clin Neurol

Publisher Elsevier

Specialty Neurology

Date 2011 Apr 19

PMID 21496625

Citations 46

Authors

Carsten G Bonnemann

Affiliations

Soon will be listed here.

Abstract

Mutations in the genes COL6A1, COL6A2, and COL6A3, coding for three α chains of collagen type VI, underlie a spectrum of myopathies, ranging from the severe congenital muscular dystrophy-type Ullrich (UCMD) to the milder Bethlem myopathy (BM), with disease manifestations of intermediate severity in between. UCMD is characterized by early-onset weakness, associated with pronounced distal joint hyperlaxity and the early onset or early progression of more proximal contractures. In the most severe cases ambulation is not achieved, or it may be achieved only for a limited period of time. BM may be of early or later onset, but is milder in its manifestations, typically allowing for ambulation well into adulthood, whereas typical joint contractures are frequently prominent. A genetic spectrum is emerging, with BM being caused mostly by dominantly acting mutations, although rarely recessive inheritance of BM is also possible, whereas both dominantly as well as recessively acting mutations underlie UCMD.

Citing Articles

Segregation of the Variant (c.1817-3C>G) in a Consanguineous Saudi Family with Bethlem Myopathy.

Aldharee H, Hamdan H Genes (Basel). 2024; 15(11).

PMID: 39596604 PMC: 11593470. DOI: 10.3390/genes15111405.

A Novel Splice Site Variant in COL6A1 Causes Ullrich Congenital Muscular Dystrophy in a Consanguineous Malian Family.

Maiga A, Pamanta I, Bamba S, Cisse L, Diarra S, Toure S Mol Genet Genomic Med. 2024; 12(11):e70032.

PMID: 39523858 PMC: 11551527. DOI: 10.1002/mgg3.70032.

Distinct muscle regenerative capacity of human induced pluripotent stem cell-derived mesenchymal stromal cells in Ullrich congenital muscular dystrophy model mice.

Yokomizo-Goto M, Takenaka-Ninagawa N, Zhao C, Bourgeois Yoshioka C, Miki M, Motoike S Stem Cell Res Ther. 2024; 15(1):340.

PMID: 39370505 PMC: 11457425. DOI: 10.1186/s13287-024-03951-6.

Expert panel curation of 31 genes in relation to limb girdle muscular dystrophy.

Mohan S, McNulty S, Thaxton C, Elnagheeb M, Owens E, Flowers M Ann Clin Transl Neurol. 2024; 11(9):2268-2276.

PMID: 39215466 PMC: 11537137. DOI: 10.1002/acn3.52127.

Expert Panel Curation of 31 Genes in Relation to Limb Girdle Muscular Dystrophy.

Mohan S, McNulty S, Thaxton C, Elnagheeb M, Owens E, Flowers M bioRxiv. 2024; .

PMID: 38765987 PMC: 11100593. DOI: 10.1101/2024.05.03.592369.

References

Peat R, Baker N, Jones K, North K, Lamande S . Variable penetrance of COL6A1 null mutations: implications for prenatal diagnosis and genetic counselling in Ullrich congenital muscular dystrophy families. Neuromuscul Disord. 2007; 17(7):547-57. DOI: 10.1016/j.nmd.2007.03.017. View

Higuchi I, Shiraishi T, Hashiguchi T, Suehara M, Niiyama T, Nakagawa M . Frameshift mutation in the collagen VI gene causes Ullrich's disease. Ann Neurol. 2001; 50(2):261-5. DOI: 10.1002/ana.1120. View

Peat R, Smith J, Compton A, Baker N, Pace R, Burkin D . Diagnosis and etiology of congenital muscular dystrophy. Neurology. 2007; 71(5):312-21. DOI: 10.1212/01.wnl.0000284605.27654.5a. View

Kuo H, Maslen C, Keene D, Glanville R . Type VI collagen anchors endothelial basement membranes by interacting with type IV collagen. J Biol Chem. 1997; 272(42):26522-9. DOI: 10.1074/jbc.272.42.26522. View

Sasaki T, Gohring W, Pan T, Chu M, Timpl R . Binding of mouse and human fibulin-2 to extracellular matrix ligands. J Mol Biol. 1995; 254(5):892-9. DOI: 10.1006/jmbi.1995.0664. View

Finnis M, Gibson M . Microfibril-associated glycoprotein-1 (MAGP-1) binds to the pepsin-resistant domain of the alpha3(VI) chain of type VI collagen. J Biol Chem. 1997; 272(36):22817-23. DOI: 10.1074/jbc.272.36.22817. View

Pepe G, Lucarini L, Zhang R, Pan T, Giusti B, Quijano-Roy S . COL6A1 genomic deletions in Bethlem myopathy and Ullrich muscular dystrophy. Ann Neurol. 2005; 59(1):190-5. DOI: 10.1002/ana.20705. View

Zou Y, Zhang R, Sabatelli P, Chu M, Bonnemann C . Muscle interstitial fibroblasts are the main source of collagen VI synthesis in skeletal muscle: implications for congenital muscular dystrophy types Ullrich and Bethlem. J Neuropathol Exp Neurol. 2008; 67(2):144-54. DOI: 10.1097/nen.0b013e3181634ef7. View

Kirschner J, Hausser I, Zou Y, Schreiber G, Christen H, Brown S . Ullrich congenital muscular dystrophy: connective tissue abnormalities in the skin support overlap with Ehlers-Danlos syndromes. Am J Med Genet A. 2005; 132A(3):296-301. DOI: 10.1002/ajmg.a.30443. View

10.

Engvall E, Hessle H, Klier G . Molecular assembly, secretion, and matrix deposition of type VI collagen. J Cell Biol. 1986; 102(3):703-10. PMC: 2114116. DOI: 10.1083/jcb.102.3.703. View

11.

Lampe A, Zou Y, Sudano D, OBrien K, Hicks D, Laval S . Exon skipping mutations in collagen VI are common and are predictive for severity and inheritance. Hum Mutat. 2008; 29(6):809-22. DOI: 10.1002/humu.20704. View

12.

Baker N, Morgelin M, Peat R, Goemans N, North K, Bateman J . Dominant collagen VI mutations are a common cause of Ullrich congenital muscular dystrophy. Hum Mol Genet. 2004; 14(2):279-93. DOI: 10.1093/hmg/ddi025. View

13.

Ishikawa H, Sugie K, Murayama K, Awaya A, Suzuki Y, Noguchi S . Ullrich disease due to deficiency of collagen VI in the sarcolemma. Neurology. 2004; 62(4):620-3. DOI: 10.1212/01.wnl.0000113023.84421.00. View

14.

Aumailley M, Specks U, Timpl R . Cell adhesion to type-VI collagen. Biochem Soc Trans. 1991; 19(4):843-7. DOI: 10.1042/bst0190843. View

15.

Lampe A, Dunn D, von Niederhausern A, Hamil C, Aoyagi A, Laval S . Automated genomic sequence analysis of the three collagen VI genes: applications to Ullrich congenital muscular dystrophy and Bethlem myopathy. J Med Genet. 2005; 42(2):108-20. PMC: 1736000. DOI: 10.1136/jmg.2004.023754. View

16.

Norwood F, Harling C, Chinnery P, Eagle M, Bushby K, Straub V . Prevalence of genetic muscle disease in Northern England: in-depth analysis of a muscle clinic population. Brain. 2009; 132(Pt 11):3175-86. PMC: 4038491. DOI: 10.1093/brain/awp236. View

17.

Fitzgerald J, Rich C, Zhou F, Hansen U . Three novel collagen VI chains, alpha4(VI), alpha5(VI), and alpha6(VI). J Biol Chem. 2008; 283(29):20170-80. DOI: 10.1074/jbc.M710139200. View

18.

Atkinson J, Ruhl M, Becker J, Ackermann R, Schuppan D . Collagen VI regulates normal and transformed mesenchymal cell proliferation in vitro. Exp Cell Res. 1996; 228(2):283-91. DOI: 10.1006/excr.1996.0328. View

19.

Rafii M, Hagiwara H, Mercado M, Seo N, Xu T, Dugan T . Biglycan binds to alpha- and gamma-sarcoglycan and regulates their expression during development. J Cell Physiol. 2006; 209(2):439-47. PMC: 2929672. DOI: 10.1002/jcp.20740. View

20.

Wiberg C, Hedbom E, Khairullina A, Lamande S, Oldberg A, Timpl R . Biglycan and decorin bind close to the n-terminal region of the collagen VI triple helix. J Biol Chem. 2001; 276(22):18947-52. DOI: 10.1074/jbc.M100625200. View